22:08:40 EDT Sat 18 May 2024
Enter Symbol
or Name
USA
CA



T:VPH - VALEO PHARMA INC. J CLASS A - http://www.valeopharma.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
VPH - T  1.00.095·0.1053.00.105+0.0055.077.07290.105  0.105  0.0950.44  0.0616:00:00Apr 2515 min RT 2¢
TSX - T1.00.095·0.1053.00.105+0.0055.036.54100.105  0.105  0.0950.44  0.0616:00:0015 min
NEO ATS - U 0.1015.5190.10  0.10  0.09514:19:0015 min
Omega - O 0.095-0.005-5.07.0120.095  0.095  0.09515:57:3115 min
Pure - P 0.100.11    15 min
CX2 - H 0.095-0.005-5.017.5240.10  0.10  0.09511:02:1615 min
CXD - D 0.100.11    Apr 2215 min
TriAct - M 0.100.22    15 min

Recent Trades - Last 10 of 29
Time ETExPriceChangeVolumeBuyerSellerMarkers
16:00:00T0.1050.0054,00022 Fidelity1 AnonymousKQ
16:00:00T0.1050.0053,00022 Fidelity124 QuestradeKQ
16:00:00T0.1050.0053,00022 Fidelity7 TD SecKQ
15:57:31O0.095-0.0051,0001 Anonymous80 National BankK
15:36:13M0.095-0.005307 TD Sec39 Merrill LynchE
15:35:45T0.10 50080 National Bank7 TD SecK
14:22:39T0.10 7,0002 RBC7 TD SecK
14:21:51P0.10 13019 Desjardins36 LatimerE
14:20:39T0.10 5,0002 RBC7 TD SecK
14:19:00U0.10 5002 RBC2 RBCK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-04-25 18:00C:VPH0.095News ReleaseValeo Pharma shareholders approve all matters at AGM
2024-03-22 09:27C:VPH0.175News ReleaseValeo Pharma appoints Moghaddam as director
2024-03-15 09:16C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-15 09:10C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 17:38C:VPH0.195News ReleaseValeo Pharma loses $6.9-million in Q1 2024
2024-03-14 16:18C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-14 16:12C:VPH0.195SEDAR Interim MD & ASEDAR Interim MD & A
2024-03-14 16:12C:VPH0.195SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-03-07 09:25C:VPH0.195News ReleaseValeo Pharma to release Q1 2024 results March 14
2024-02-13 11:04C:VPH0.175News ReleaseValeo Pharma appoints Raich, Bisaillon as directors
2024-02-02 17:13C:VPH0.26News ReleaseValeo Pharma amends supply agreement with Novartis
2024-01-29 18:39C:VPH0.33SEDAR Annual Information FormSEDAR Annual Information Form
2024-01-29 18:39C:VPH0.33SEDAR Annual ReportSEDAR Annual Report
2024-01-29 18:39C:VPH0.33SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-01-29 18:39C:VPH0.33SEDAR MD & ASEDAR MD & A
2024-01-29 18:05C:VPH0.33News ReleaseValeo Pharma loses $27.8-million in fiscal 2023
2024-01-22 10:16C:VPH0.33News ReleaseValeo Pharma to release fiscal 2023 results Jan. 29
2023-11-20 10:24C:VPH0.18News ReleaseValeo Pharma to reduce $2M in operating costs
2023-11-07 13:14C:VPH0.145News ReleaseValeo Pharma appoints Lajoie as director
2023-09-27 10:11C:VPH0.235News ReleaseValeo enters $5M credit facility agreement with Accord